Spelling Mistake Tolerant Word Prediction for Working, Writing and Communicating
NCT ID: NCT04210661
Last Updated: 2022-03-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2020-02-13
2022-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The effectiveness of written communication is defined in this study by the number of spelling errors for each user. Word prediction (and therefore correction) must be able to be configured by a therapist (speech therapist, occupational therapist).
Adapting the prediction to user errors should also allow it to be more relevant throughout the text input. This software efficiency must increase text input speed, Reduce the cognitive load, establish a classification of spelling errors adapted to the context of text input speed and develop the word prediction module tolerant of these spelling errors.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Orthophonic and / or Proprioceptive Treatment of Developmental Dyslexia.
NCT03448237
Developmental Dyslexia and Remediation Methods
NCT04028310
Acquired Dyslexia Modeling and Treatment
NCT07209488
Handwritten Text Production in Adults With Autism
NCT06304701
Assessing the Generalizability of the Tachidino Protocol to Different Clinical Contexts
NCT04384718
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
classic prediction software
test with classic precition software
prediction software with spell checker
test with prediction software with spell checker
prediction software with spell checker
test with prediction software with spell checker
prediction software with spell checker
test with prediction software with spell checker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prediction software with spell checker
test with prediction software with spell checker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient with dysorthographia
* educational level greater than or equal to CE2
* A developmental level in reading on the Evalouette test (Evaleo battery) greater than or equal to CE1 For center 2
* Neurologic disorder impacting communication
Exclusion Criteria
* Persons under guardianship
* Pregnant women
* No affiliation to a social security scheme (beneficiary or beneficiary)
* Having visual disturbances preventing the use of the computer tool
6 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Investigation Clinique et Technologique 805
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Raymond Poincaré hospital
Garches, , France
CMRRF Kerpape
Ploemeur, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01882-55
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.